
B-Raf inhibitor 1 dihydrochloride
CAS No. 1191385-19-9
B-Raf inhibitor 1 dihydrochloride( B-Raf inhibitor 1 dihydrochloride )
Catalog No. M17180 CAS No. 1191385-19-9
B-Raf inhibitor 1 is a potent and selective B-Raf inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 52 | Get Quote |
![]() ![]() |
5MG | 95 | Get Quote |
![]() ![]() |
10MG | 170 | Get Quote |
![]() ![]() |
25MG | 284 | Get Quote |
![]() ![]() |
50MG | 422 | Get Quote |
![]() ![]() |
100MG | 618 | Get Quote |
![]() ![]() |
500MG | 1305 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameB-Raf inhibitor 1 dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionB-Raf inhibitor 1 is a potent and selective B-Raf inhibitor.
-
DescriptionB-Raf inhibitor 1 dihydrochloride is a novel potent and selective B-Raf inhibitor.
-
In VitroB-Raf inhibitor 1 (Compound 13) inhibits A375 and HCT-116 proliferation with IC50s of 0.31 and 0.72 μM, respectively. B-Raf inhibitor 1 (Compound 13) binds to and stabilizes B-Raf in a DFG-out, inactive conformation in which the ATP pocket is partially filled by Phe595 and Gly596 from the DFG motif. B-Raf inhibitor 1 (Compound 13) additionally exhibits low micromolar inhibition against wild type B-Raf cell lines, which may be due to off-target kinase activities or alternatively to pan-Raf inhibition, including Raf dimers.
-
In Vivo——
-
SynonymsB-Raf inhibitor 1 dihydrochloride
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptorB-Raf
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1191385-19-9
-
Formula Weight478.94
-
Molecular FormulaC26H19ClN8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1c(c2c(cc1)c(ncc2)Nc1ccc(cc1)Cl)Nc1c(cccn1)c1c2c(ncn1)nc[nH]2.Cl.Cl
-
Chemical Name1-N-(4-Chlorophenyl)-6-methyl-5-N-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine dihydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang X, et al. J Med Chem. 2012 Sep 13;55(17): 7332-41.
molnova catalog



related products
-
Actein
Actein has a stimulatory effect on osteoblastic bone formation or has potential activity against osteoporosis, it also can prevent oxidative damage to osteoblasts in osteoporotic patients.
-
Sennidin A
Sennidin A has two hydroxyanthraquinone-like moieties exerts inhibition on NS3 helicase with IC50 values of 0.8 μM.
-
Ipatasertib dihydroc...
Ipatasertib dihydrochloride is a highly selective and ATP-competitive inhibitor of pan-Akt (IC50s: 5, 18 and 8 nM for Akt1, Akt2 and Akt3, respectively).